Cargando…
Trends in Oncology Clinical Trials Launched Before and During the COVID-19 Pandemic
This cohort study evaluates the association of the coronavirus disease 2019 (COVID-19) pandemic with clinical research and development for cancer by studying the initiation of oncology clinical trials over time.
Autores principales: | Lamont, Elizabeth B., Diamond, Sheila S., Katriel, Ron G., Ensign, Lisa L., Liu, Jingshu, Rusli, Emelly, Alexander, G. Caleb |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841452/ https://www.ncbi.nlm.nih.gov/pubmed/33502481 http://dx.doi.org/10.1001/jamanetworkopen.2020.36353 |
Ejemplares similares
-
The Launch of the Advanced Practitioner Society for Hematology and Oncology (APSHO)
por: Viale, Pamela Hallquist, et al.
Publicado: (2014) -
Challenges in launching multinational oncology clinical trials in India
por: Saini, Kamal S., et al.
Publicado: (2013) -
A virtual-hybrid approach to launching a cardio-oncology clinic during a pandemic
por: Brown, Sherry-Ann, et al.
Publicado: (2021) -
Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic
por: Kouzy, Ramez, et al.
Publicado: (2020) -
The Payer's Dilemma: Recognizing the Uncertainty of Clinical and Economic Evidence at Product Launch
por: Watkins, John B., et al.
Publicado: (2009)